Fabrication and characterization of bioactive glass/hydroxyapatite nanocomposite foam by gelcasting method
Source abstract
Abstract
Abstract Bioceramic foams have been applied for drug releasing agents, cell loading, and widely for hard tissue scaffold. The aim of this study was fabrication and characterization of nanostructure bioceramic composite foam (BCF) consisting of hydroxyapatite (HA) and bioactive glass (BG) via gelcasting method for applications in tissue engineering. X-ray diffraction (XRD), scanning electron microscopy (SEM), and transmission electron microscopy (TEM) analysis techniques were utilized in order to evaluate respectively, phase composition, dimension, morphology, and interconnectivity of pores, and particle size of synthesized HA, BG, and BCF. The results showed that fabrication of the BCF with a particle size in the range 20–42 nm and pore size in the range 100–250 μm was successfully performed. The maximum values of compressive strength and elastic modulus of the BCF were found to be about 1.95 MPa and 204 MPa, respectively, related to a sample sintered at 900 °C for 4 h. The mean values of the true (total) and apparent (interconnected) porosity were calculated in the range 86–91% and 60–71%, respectively. It seems that the measured properties make the BCF a good candidate for tissue engineering applications, preferentially in drug delivery, cell loading, and other nonloading applications.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Facial Trauma and Fracture Management · Dental Implant Techniques and Outcomes
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (30)
Show source-provided references
1. Bioactive glass scaffolds for bone regeneration10.2113/GSELEMENTS.3.6.393 ↗
2. Ratner · 2004
3. Lanza · 1997
4. Porous hydroxyapatite for artificial bone applications10.1016/j.stam.2006.11.017 ↗
5. Hydroxyapatite foams produced by gelcasting using agarose10.1016/j.matlet.2007.07.043 ↗
6. Manufacturing of highly porous calcium phosphate bioceramics via gel-casting using agarose10.1016/j.ceramint.2008.12.006 ↗
7. Properties of highly porous hydroxyapatite obtained by the gelcasting of foams10.1111/j.1151-2916.2000.tb01677.x ↗
8. Hydroxyapatite nanoparticles: a review of preparation methodologies
9. Cullity · 1978
10. Askeland · 1989
11. Preparation of porous hydroxyapatite scaffolds by combination of the gel-casting and polymer sponge methods10.1016/S0142-9612(03)00171-6 ↗
12. Tissue reaction to three ceramics of porous and non-porous structures10.1002/jbm.820060505 ↗
13. Hulbert · 1971 · 417
14. Enhanced surface and mechanical properties of nanophase ceramics to achieve orthopaedic/dental implant efficacy10.4028/www.scientific.net/KEM.192-195.321 ↗
15. Enhanced functions of osteoblasts on nanophase ceramics10.1016/S0142-9612(00)00075-2 ↗
16. Specific proteins mediate enhanced osteoblast adhesion on nanophase ceramics10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.0.CO;2-9 ↗
17. Bioceramics for tissue engineering applications10.3844/ajbbsp.2006.49.56 ↗
18. 45S5 bioglass derived glass–ceramic scaffolds for bone tissue engineering10.1016/j.biomaterials.2005.11.025 ↗
19. Bioactive glass and hybrid scaffolds prepared by sol–gel method for bone tissue engineering10.1111/j.1151-2916.1998.tb02540.x ↗
20. Porous ceramic bodies for drug delivery10.1023/A:1008988127294 ↗
21. Potential use of gelcasting hydroxyapatite porous ceramic as an implantable drug delivery system10.1016/S0378-5173(00)00659-1 ↗
22. Evaluation of a bioceramic-based nanocomposite material for controlled delivery of a non-steroidal anti-inflammatory drug10.1016/j.medengphy.2009.07.019 ↗
23. Local drug delivery system using ceramics: vacuum method for impregnating a chemotherapeutic agent into a porous hydroxyapatite block10.1023/A:1008966314075 ↗
24. Stem cell technology and bioceramics: from cell to gene engineering10.1002/(SICI)1097-4636(1999)48:6<913::AID-JBM22>3.0.CO;2-0 ↗
25. Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: implications for their use in cell therapy10.1016/S0301-472X(00)00160-0 ↗
26. Fabrication and characterization of porous hydroxyapatite ocular implant followed by an in vivo study in dogs10.1007/BF02708495 ↗
27. Preparation and characterization of sol–gel bioactive glass coating for improvement of biocompatibility of human body implant10.1016/j.msea.2007.05.041 ↗
28. Evaluation and characterization of nanostructure hydroxyapatite powder prepared by simple sol–gel method10.1016/j.matlet.2007.01.028 ↗
29. Bone tissue engineering with porous hydroxyapatite ceramics10.1007/s10047-005-0292-1 ↗
30. Effect of surfactant concentration and composition on the structure and properties of sol–gel-derived bioactive glass foam scaffolds for tissue engineering10.1023/A:1025988301542 ↗